Manasa Kanneganti

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/7894f530-0091-11ee-884f-2d0b9345d99c.jpg

First Name

Manasa

Last Name

Kanneganti

NPI

1558756528

Faculty ID

17495

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

76439

Biography

<p>Manasa Kanneganti, MD, is a vascular surgeon at Montefiore Medical Center and Assistant Professor of Surgery at Albert Einstein College of Medicine. Dr. Kanneganti&rsquo;s clinical focus centers on peripheral arterial disease and diabetic foot ulcers with a focus on limb salvage, venous insufficiency, hemodialysis access, aortic disease, thoracic outlet syndrome, mesenteric insufficiencies and sclerotherapy.</p><p>After receiving her Bachelor of Arts in medical sciences and psychology from Boston University College of Arts and Sciences in 2012, Dr. Kanneganti earned her Doctor of Medicine at Boston University School of Medicine in 2015. She continued her medical training at Montefiore Medical Center, completing a general surgery internship in 2016 and her general surgery residency in 2020. She then completed a vascular surgery fellowship at the University of Virginia in 2022.</p><p>Dr. Kanneganti&rsquo;s research interests include hemodialysis access, thoracic outlet syndrome and limb salvage. Her work has been shared through numerous peer-reviewed publications, book chapters, abstract presentations, invited lectures and expert panels. She is also a reviewer for the Journal of Vascular Surgery.</p><p>Dr. Kanneganti is board certified by the American Board of Surgery in General Surgery and Vascular Surgery. She is a member of several professional organizations, including the Society for Vascular Surgery, the Society for Clinical Vascular Surgery and the Vascular and Endovascular Surgery Society, among others.</p>

Is Open Scheduling

Off

Rui Yang

https://assets.montefioreeinstein.org/profiles/images/physphoto/Yang_Rui_MD_420x504.jpg

First Name

Rui

Last Name

Yang

NPI

1215280532

Faculty ID

9892

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Yang earned his medical degree at Beijing Medical University in China followed by an orthopaedic residency at Peking University People&rsquo;s Hospital in Beijing, China.&nbsp; Following his training in China, he came to the United States where he earned a Master&rsquo;s degree in Biological Sciences from Hunter College at the City University of New York. Dr. Yang completed a second orthopaedic surgery residency at the University of Texas, in Houston and then he did a fellowship in Orthopaedic Oncology at Memorial Sloan-Kettering Cancer Center.</p>
<p>Dr. Yang specializes in the diagnosis and treatment of benign and malignant tumors in the musculoskeletal system. A multidisciplinary approach is emphasized in his practice. He performs surgery to remove the tumor fom the limb and pelvis, and rebuild them using techniques tailored for each individual patient. Dr. Yang is also interested in treating metastatic bony lesions originating from other parts of the body.</p>
<p>Dr. Yang has a strong interest in the research of musculoskeletal tumors. He has been studying the tumorigenesis of osteosarcoma and the genetic profile of the tumors as comparison to its normal counterpart tissues.&nbsp; He has also studied the mechanism of chemotherapy resistance in osteosarcoma and related signaling pathways, as well as novel strategies to overcome it in collaboration with the pediatric sarcoma teams.</p>
<p>&nbsp;</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Diagnosis and treatment of benign and malignant tumors in the musculoskeletal system, including metastatic bony lesions as well as primary tumors.<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Yang has a strong interest in the research of musculoskeletal tumors. He has been studying the tumor genesis of osteosarcoma and the genetic profile of the tumors as compared to normal counterpart tissues. He has also studied the mechanism of chemotherapy resistance in osteosarcoma and related signaling pathways, in addition to novel strategies to overcome it in collaboration with pediatric sarcoma teams.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p>1. Peer-reviewed Papers</p>
<p>1) <strong>Yang, R.</strong>, Piperdi, S.,&nbsp; Zhang, Y., Neophytou, N., Zhu, W., Hoang, B.H., Mason, G., Geller, D., Dorfman, H,, Healey, J.H., Phinney, D.G., and Gorlick, R. Transcriptional Profiling Identifies the Signaling Axes of the Insulin Growth Factor and the Transforming Growth Factor-beta as involved in the Pathogenesis of Osteosarcoma. Clin Orthop Relat Res. 2015. PMID: 26463566</p>
<p>2) Nathan, S.S., Huvos, A.G., Casas-Ganem, J.E., <strong>Yang, R.,</strong> Linkov, I., Sowers, R., DiResta, G.R., Gorlick, R., Healey, J.H.&nbsp;Tumour interstitial fluid pressure may regulate angiogenic factors in osteosarcoma <a href="http://www.ncbi.nlm.nih.gov/pubmed/20052438">.</a&gt; Ann Acad Med Singapore. 2009; 38(12):1041-7. PMID: 20052438</p>
<p>3) Li, N., <strong>Yang, R.</strong>, Zhang, W., Dorfman, H., Rao, P., and Gorlick, R. Genetically Transforming Human Mesenchymal Stem Cells to Sarcomas: changes in cellular phenotype and multilineage differentiation potential. Cancer. 2009; 115(20): 4795-806. PMID: 19593798</p>
<p>4) <strong>Yang, R</strong>., Piperdi, S., and Gorlick, R. Activation of the RAF/MEK/ERK pathway mediates apoptosis induced by chelerythrine in osteosarcoma. Clin Cancer Res. 2008;14(20): 6396-404. PMID: 18927278</p>
<p>5) <strong>Yang, R.</strong>, Qin, J., Hoang, B.H., Healey, J.H., and Gorlick, R. Polymorphisms and methylation of the reduced folate carrier in osteosarcoma. Clin Orthop Relat Res 2008;466:2046-51. PMID: 18528741</p>
<p>6) Nathan, S.S., Huvos, A.G., Casas-Ganem, J.E., <strong>Yang, R.</strong>, Linkov, I., Sowers, R., Diresta, G.R., Gorlick, R., and Healey, J.H. Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. J Orthop Res 2008;26:1-6. PMID: 18473395</p>
<p>7) <strong>Yang, R.</strong>, Li, W.W., Hoang, B.H., Kim, H., Banerjee, D., Kheradpour, A., Healey, J.H., Meyers, P.A., Bertino, J.R., and Gorlick, R. Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier. BMC Cancer 2008;8:124. PMID: 18452618</p>
<p>8) <strong>Yang, R.</strong>, Kolb, E.A., Qin, J., Chou, A., Sowers, R., Hoang, B., Healey, J.H., Huvos, A.G., Meyers, P.A. and Gorlick, R. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate. Clin Cancer Res 2007;13:2557-67. PMID: 17473184</p>
<p>9) <strong>Yang, R.</strong>, Hoang, B.H., Kubo, T., Kawano, H., Chou, A., Sowers, R., Huvos, A.G., Meyers, P.A., Healey, J.H. and Gorlick, R. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma. Int J Cancer 2007;121:943-54. PMID: 17410535</p>
<p>10) Laverdiere, C., Hoang, B.H., <strong>Yang, R.</strong>, Sowers, R., Qin, J., Meyers, P.A., Huvos, A.G., Healey, J.H. and Gorlick, R. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 2005;11:2561-7. PMID: 15814634</p>
<p>11) Nathan, S.S., DiResta, G.R., Casas-Ganem, J.E., Hoang, B.H., Sowers, R., <strong>Yang, R.</strong>, Huvos, A.G., Gorlick, R. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clin Cancer Res 2005;11:2389-97. PMID: 15788690</p>
<p>12) Flintoff, W.F., Sadlish, H., Gorlick, R., <strong>Yang, R.</strong>, Williams, F.M. Functional analysis of altered reduced folate carrier sequence changes identified in osteosarcomas. Biochim Biophys Acta 2004;1690:110-7. PMID: 15469899</p>
<p>13) Hoang, B.H., Kubo, T., Healey, J.H., <strong>Yang, R.</strong>, Nathan, S.S., Kolb, E.A., Mazza, B., Meyers, P.A. and Gorlick, R. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res 2004;64:2734-9. PMID: 15087387</p>
<p>14) Hoang, B.H., Kubo, T., Healey, J.H., Sowers, R., Mazza, B., <strong>Yang, R.</strong>, Huvos, A.G., Meyers, P.A. and Gorlick, R. Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma. Int J Cancer 2004;109:106-11. PMID: 14735475</p>
<p>15) <strong>Yang, R.</strong>, Sowers, R., Mazza, B., Healey, J.H., Huvos, A., Grier, H., Bernstein, M., Beardsley, G.P., Krailo, M.D., Devidas, M., Bertino, J.R., Meyers, P.A. and Gorlick, R. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples. Clin Cancer Res 2003;9:837-44. PMID: 12576457</p>
<p>&nbsp;</p>
<p>2. Book Chapters</p>
<p align="left">1) Orthopedic Oncology. Editor: Xun, W.P., Feng, C.H. People&rsquo;s Military Medical Publisher.</p>
<p>(ISBN: 7-80157-159-2), 2001.</p>
<p>2) Review of Surgery: A Guiding Book for Medical Students. Section of Orthopedics. Editor: Jiang, B.G. Beijing Medical University Publisher.&nbsp; (ISBN: 7-81034-946-5), 1999.</p>

EMR ID

78569

Biography

<p>Dr. Yang is a fellowship-trained orthopedic surgeon recognized for his multidisciplinary approach to the diagnosis and treatment of benign and malignant tumors in the musculoskeletal system, including metastatic bony lesions as well as primary tumors. He also serves as an Assistant Professor at our Albert Einstein College of Medicine.</p><p>Dr. Yang earned his medical degree at Beijing Medical University in China followed by an orthopedic residency at Peking University People?s Hospital in Beijing, China. Following his training in China, he came to the United States where he earned a master?s degree in biological sciences from Hunter College at the City University of New York. Dr. Yang completed a second orthopedic surgery residency at the University of Texas, in Houston, followed by a fellowship in orthopedic oncology at Memorial Sloan-Kettering Cancer Center.</p><p>Dr. Yang has a strong interest in the research of musculoskeletal tumors. He has been studying the tumor genesis of osteosarcoma and the genetic profile of the tumors as compared to normal counterpart tissues. He has also studied the mechanism of chemotherapy resistance in osteosarcoma and related signaling pathways, in addition to novel strategies to overcome it in collaboration with pediatric sarcoma teams.</p>

Is Open Scheduling

Off

Marc Vimolratana

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/58a00310-6a8c-11ec-afc2-e529147b8d1e.jpg

First Name

Marc

Last Name

Vimolratana

NPI

1467870683

Faculty ID

17157

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Vimolratana is a general thoracic surgeon with a clinical focus on thoracic surgical oncology, including minimally invasive surgery for lung and esophageal cancer. His other clinical interests include mediastinal and chest wall tumors, tracheal disorders, thoracic outlet syndrome, and benign esophageal diseases.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Vimolratana&rsquo;s research focuses on improving patient outcomes after complex lung and esophageal surgery. He has shared his findings through publications in peer-reviewed journals and abstracts at national meetings.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

163553

Biography

<p>Marc Vimolratana, MD, MS, is Assistant Professor, Cardiothoracic and Vascular Surgery at Montefiore Einstein. Dr. Vimolratana is a general thoracic surgeon with a clinical focus on thoracic surgical oncology, including minimally invasive surgery for lung and esophageal cancer. His other clinical interests include mediastinal and chest wall tumors, tracheal disorders, thoracic outlet syndrome, and benign esophageal diseases. Dr. Vimolratana takes a patient-centered approach to patient care and is committed to using minimally invasive techniques, including VATS and robotic surgery, whenever possible to minimize surgical trauma and pain for patients.</p><p>Dr. Vimolratana studied chemistry at Yale, earning a Bachelor of Science and Master of Science in 2006. He attended medical school at the University of California, San Francisco, earning a Doctor of Medicine in 2014. After many years in California, he moved to New York for postdoctoral training at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, where he completed a residency in general surgery in 2019, serving as chief resident in his final year. Dr. Vimolratana continued at NewYork-Presbyterian Hospital for fellowship training in cardiothoracic surgery prior to joining the faculty at Montefiore Einstein in 2021.</p><p>Dr. Vimolratana&rsquo;s research focuses on improving patient outcomes after complex lung and esophageal surgery. He has shared his findings through publications in peer-reviewed journals and abstracts at national meetings.</p><p>Dr. Vimolratana is certified by the American Board of Thoracic Surgery and the American Board of Surgery. He is a member of several professional organizations, including the American College of Surgeons, the Society of Thoracic Surgeons and the European Society of Thoracic Surgeons. He has been honored with numerous awards for academic excellence and clinical care.</p>

Is Open Scheduling

Off

Sonia S. Talathi

https://assets.montefioreeinstein.org/profiles/images/physphoto/Talathi_Sonia_MD_420x504.jpg

First Name

Sonia

Last Name

Talathi

NPI

1578805941

Faculty ID

16753

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<span style="color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">Dr. Talathi specializes in endovascular and surgical treatments for the management of vascular diseases.&nbsp;</span><quillbot-extension-portal></quillbot-extension-portal>

Research Focus

<span style="color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;">Her research interests include peripheral vascular disease, dialysis access and quality improvement.</span><quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

EMR ID

56693

Biography

<p style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);margin-bottom:0px;color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;"><span style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);">Sonia S. Talathi, MD, is a Vascular Surgeon at Montefiore and Assistant Professor of Cardiothoracic and Vascular Surgery at Albert Einstein College of Medicine. Dr. Talathi received her medical degree from the University of Alabama at Birmingham School of Medicine and later completed her residency in general surgery at Montefiore-Einstein, where she served as Administrative Chief Resident. She went on to complete her fellowship in vascular surgery at Northwell Health in Long Island, New York, and was subsequently named Fellow Teacher of the Year.&nbsp;</span></p><p style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);margin-top:2rem;margin-bottom:0px;color:#313335;font-family:'Leitura News', Georgia, Cambria, 'Times New Roman', Times, serif;font-size:medium;background-color:#ffffff;"><span style="box-sizing:border-box;border:0px solid rgb(226, 232, 240);">Dr. Talathi specializes in endovascular and surgical treatments for the management of vascular diseases. Her research interests include peripheral vascular disease, dialysis access and quality improvement. She has published multiple scientific papers and presented at numerous national meetings.&nbsp;</span></p>

Is Open Scheduling

Off

Brendon M. Stiles

https://assets.montefioreeinstein.org/profiles/images/Stiles_Brendon_MD_2x.jpg

First Name

Brendon

Last Name

Stiles

NPI

1013176387

Faculty ID

16884

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p class="MsoNoSpacing">Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic &amp; Vascular Surgery at Montefiore-Einstein.&nbsp; Dr. Stiles is also the Associate Director for Surgical Services in the Montefiore-Einstein Cancer Center. Dr. Stiles&rsquo; clinical focus is on the treatment of lung and esophageal cancer and on neoadjuvant immunotherapy. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.</p>
<p class="MsoNoSpacing">Dr. Stiles is also heavily involved with translational and basic research.&nbsp; Translationally, Dr. Stiles is interested in neoadjuvant immunotherapy and in predicting and augmenting response to immunotherapy.&nbsp; &nbsp;In the laboratory, he has been funded by the AATS, TSF, the Lung Cancer Research Foundation, the DOD CDMRP Lung Cancer Research Program, and the Mark Foundation.&nbsp;</p>
<p class="MsoNoSpacing">Dr. Stiles' laboratory currently investigates the protein ART1, an extracellular mono-ADP-ribosyltransferase.&nbsp; Recently, Dr. Stiles and his team discovered that ART1 may play an important role in one mechanism of resistance in lung cancers. ART1 mono-ADP-ribosylates the P2X7 receptor (P2X7R) on immune cells, which ultimately causes NAD-induced cell death (NICD) in T cells, macrophages, and dendritic cells. They found ART1 to be highly expressed in multiple human non-small cell lung cancer cell lines and in the majority of human lung adenocarcinomas they sampled.<span style="mso-spacerun: yes;">&nbsp; </span>ART1 expression allows cancers to blunt the immune response against them. Indeed, they found that inhibiting ART1 with a therapeutic monoclonal antibody in mouse models of lung cancer caused a dramatic reduction of tumor burden and an enrichment of immune cells in the tumor.</p>
<p class="MsoNoSpacing"><span style="font-size: 12pt;">Current efforts are underway to better understand regulation of ART1 expression, to identify more targets of extracellular mono-ADP-ribosylation, and to refine pre-clincal models to test their therapeutic antibody targeting ART1.</span></p>
<p class="MsoNoSpacing">&nbsp;</p>
<p class="MsoNoSpacing">&nbsp;</p>

Research Areas

Specialties

Expert Tags

Areas of Expertise

Expert Summary

<p>Dr. Stiles’ clinical focus is on the treatment of lung and esophageal cancer and on neoadjuvant immunotherapy. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.
</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Stiles&rsquo; clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases.&nbsp;<quillbot-extension-portal></quillbot-extension-portal>

Research Focus

Dr. Stiles is actively involved in both clinical and translational research, particularly focusing on lung cancer. His clinical research concentrates on the management of early stage or screen detected lung cancer and on novel multidisciplinary treatment strategies for patients with lung cancer.&nbsp; In the laboratory, he investigates a protein called ART1 and its role in protecting cancer cells from the immune system. He has developed a novel drug targeting ART1 with a goal of advancing it to clinical use. He has co-authored numerous manuscripts on the management of early stage or screen-detected lung cancer, guidelines for the management of early stage lung cancer, papers regarding neoadjuvant immunotherapy for lung cancer patients and a comprehensive review on the tumor microenvironment in lung cancer.<quillbot-extension-portal></quillbot-extension-portal>

Elsevier Profile

Selected Publications

<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif;">Wennerberg, Erik et al, Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.&nbsp;&nbsp;<em>Science Translational Medicine.&nbsp;</em>2022 Mar 16;14(636):eabe8195.&nbsp;&nbsp;</span><u style="font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14px;"><span style="font-size: 11.0pt; font-family: 'Calibri',sans-serif; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; color: #0563c1; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><a href="https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.s…;
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Altorki, Nasser K., et al. "The lung microenvironment: an important regulator of tumour growth and metastasis."&nbsp;</span><em style="font-size: 12pt;"><span style="font-family: Arial, sans-serif;">Nature Reviews Cancer</span></em><span style="font-size: 12pt;">&nbsp;19.1 (2019): 9-31.</span></p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Yao, Zhan, et al. "TGF-&beta; IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">Proceedings of the National Academy of Sciences</span></em>&nbsp;107.35 (2010): 15535-15540.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Gao, Dingcheng, et al. "Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">Cancer research</span></em>&nbsp;72.6 (2012): 1384-1394.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Altorki, Nasser K., et al. "Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: A single-centre, randomised phase 2 trial."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">The Lancet Oncology</span></em>&nbsp;22.6 (2021): 824-835.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Wennerberg, Erik, et al. "Expression of ART1, an extracellular mono ADP-ribosylase, promotes lung cancer growth and dissemination by limiting tumor infiltration of P2X7R+ CD8+ T cells and CD103+ dendritic cells."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">JOURNAL FOR IMMUNOTHERAPY OF CANCER</span></em>. Vol. 7. CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND: BMC, 2019.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">Chen, Chuang, et al. "ART1, an extracellular ADP-ribosyltransferase, is over-expressed in non-small cell lung cancer and facilitates cancer cell survival by immune-mediated mechanisms."&nbsp;</span><em><span style="font-family: Arial, sans-serif;">Journal of Thoracic Oncology</span></em>&nbsp;11.2 (2016): S44.</p>
<p style="margin-right: 0in; margin-left: 0in; font-size: 12pt; font-family: 'Times New Roman', serif;"><span style="font-family: Arial, sans-serif; color: #222222;">https://scholar.google.com/citations?user=fR4OkgkAAAAJ&amp;hl=en&amp;oi…;

EMR ID

82842

Biography

<p>Brendon Stiles, MD, is Professor and Chief, Thoracic Surgery and Surgical Oncology, Department of Cardiothoracic &amp; Vascular Surgery at Montefiore Einstein, and the Associate Director for Surgical Services in the Montefiore Einstein Cancer Center. Dr. Stiles&rsquo; clinical focus is on the treatment of lung and esophageal cancer and unusual thoracic cancers including metastatic tumors and those invading the heart. He also has a clinical interest in treating benign chest and upper gastrointestinal diseases. Taking a patient-first philosophy, Dr. Stiles provides world-class personalized care, using minimally invasive, organ-sparing techniques and targeting surgical therapy to the specific needs of the patient and his or her individual tumor.</p><p>&ldquo;The recruitment of&nbsp;Dr. Stiles elevates the treatment of lung cancer to a historic level,&rdquo; said Robert E. Michler, MD, Surgeon-in-Chief and Chairman and Professor, Department of Surgery and Department of Cardiothoracic &amp; Vascular Surgery at Montefiore-Einstein. &ldquo;Every thoracic surgical therapy available anywhere in the world will now be offered by Dr. Stiles at Montefiore-Einstein.&rdquo;</p><p>After earning his Bachelor of Arts in 1994 at the University of Virginia, Dr. Stiles continued at UVA, earning his Doctor of Medicine in 1999.&nbsp; He conducted his training in general surgery at the University of Virginia Health System. From 2001 to 2003, Dr. Stiles served as a surgical research fellow at Memorial Sloan-Kettering Cancer Center before returning to the University of Virginia Health System to complete his surgical residency. Dr. Stiles completed a cardiothoracic surgery residency at NewYork-Presbyterian Hospital-Weill Cornell and Memorial Sloan-Kettering Cancer Center in 2008. Dr. Stiles joined the faculty at NewYork-Presbyterian Hospital-Weill Cornell before being recruited by Dr. Michler to Montefiore-Einstein in 2021.</p><p>Dr. Stiles is actively involved in both clinical and translational research, particularly focusing on lung cancer. His clinical research concentrates on the management of early stage or screen detected lung cancer and on novel multidisciplinary treatment strategies for patients with lung cancer.&nbsp; In the laboratory, he investigates a protein called ART1 and its role in protecting cancer cells from the immune system. He has developed a novel drug targeting ART1 with a goal of advancing it to clinical use. He has co-authored numerous manuscripts on the management of early stage or screen-detected lung cancer, guidelines for the management of early stage lung cancer, papers regarding neoadjuvant immunotherapy for lung cancer patients and a comprehensive review on the tumor microenvironment in lung cancer. In addition to publications in peer-reviewed journals, he has also given several invited national and international talks on his research and on the clinical management of lung and esophageal cancer.</p><p>Dr. Stiles is highly active in the lung cancer care community, having lost his own father to lung cancer in 2005. He is committed to raising money for lung cancer research, serving as chair of the Lung Cancer Research Foundation since 2017. He is also an invited member of the National Lung Cancer Roundtable and on the Lung-RADS Steering Committee for lung cancer screening with the American College of Radiology.&nbsp; Dr. Stiles is a member of several professional organizations including the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, the American Society of Clinical Oncology, the European Society of Thoracic Surgeons and the International Association for the Study of Lung Cancer.</p>

Is Open Scheduling

Off

Jacob F. Schulz

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/c2543d00-62a1-11ec-9a9d-5b7df90faea8.jpg

First Name

Jacob

Last Name

Schulz

NPI

1598977837

Faculty ID

13718

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

<p>Pediatric orthopedic care, spinal deformity, neuromuscular disease and trauma</p>

Research Focus

<p>Early-onset and idiopathic scoliosis, fracture care, neuromuscular disease</p>

Elsevier Profile

EMR ID

5618

Biography

<p>Jacob F. Schulz, MD, is a board-certified orthopedic surgeon who provides comprehensive pediatric orthopedic care with an emphasis on spinal deformity, neuromuscular disease and trauma. He has a particular interest in the growing spine, with experience using the vertical expandable titanium rib (VEPTR) device and vertebral tethering through a thoracoscopic approach. At our Albert Einstein College of Medicine, he is an Assistant Professor of Orthopedic Surgery.</p><p>He served both his internship and residency at the Albert Einstein Medical Center in Philadelphia where he was honored with the Frank Hammond Sivitz and Chief Resident Teaching Awards in 2011. During his residency, he traveled to Neustadt, Germany to study spine deformity at the Schoen Clinic, and to San Pedro Sula in Honduras to help CURE International provide world class orthopedic care to children. Dr. Schulz completed his fellowship in pediatric orthopedics and scoliosis at Rady Children&rsquo;s Hospital-San Diego, ranked second by <em>U.S. News &amp; World Report</em> in 2012.</p><p>Dr. Schulz&rsquo;s research has been published in The Journal of Pediatric Orthopedics (JPO) and presented at several national meetings. He is an active member of the American Academy of Orthopedic Surgeons (AAOS) and the Pediatric Orthopedic Society of North America (POSNA).</p>

Is Open Scheduling

On

Evan C. Lipsitz

https://assets.montefioreeinstein.org/profiles/images/physphoto/Lipsitz_Evan_C_MD_11112939.jpg

First Name

Evan

Last Name

Lipsitz

NPI

1255413407

Faculty ID

2940

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>A vascular surgeon, Dr. Lipsitz' research interests include the treatment of thoracic and abdominal aortic aneurysms, accessing them via the affected vessels using what clinicians call endovascular techniques.&nbsp; He investigates the role of wireless pressure-sensor technology in association with such treatment, and he has evaluated the use of endovascular stent-graft technology in the treatment of traumatic lesions.</p>
<p>&nbsp;</p>
<p>Dr. Lipsitz' research also has focused on limb salvage and the treatment of lower extremity peripheral vascular disease (PVD), the obstruction of large arteries to the legs. In treating PVD, he has studied both open surgical and endovascular techniques. He helped to popularize subintimal angioplasty in the U.S. The technique opens a totally occluded blood vessel using a wire passed within the wall of the vessel but not within the occluded "true" lumen, or inner open space, of the vessel. Once the wire is in place, a balloon is used to open the pathway.</p>
<p>&nbsp;</p>
<p>Additionally, Dr. Lipsitz maintains an active interest in the non-invasive laboratory diagnosis of vascular disease.&nbsp; He studies carotid artery disease and stroke prevention, and has evaluated the role of cerebral protection during carotid artery angioplasty and stenting. Cerebral protection seeks to minimize trauma to the brain during surgery by employing drugs and techniques, including positioning and specialized monitoring.</p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Endovascular Thoracic and Abdominal Aortic Aneurysm repair, Aortic dissection, Carotid Artery Disease and Stroke prevention, Lower extremity peripheral arterial disease and limb salvage, Endovascular and open treatments for aneurysms and peripheral arterial disease</p>

Research Focus

<p>Dr Lipsitz&rsquo; research interest includes the treatment of thoracic and abdominal aneurysms with endovascular graft technology. He has been an investigator in clinical trials of numerous grafts and has evaluated the efficacy of wireless pressure sensors and endostaples as adjunctive therapies utilized with these grafts.</p><p>Dr. Lipsitz' research has also focused on limb salvage and the treatment of lower extremity peripheral vascular disease (PVD), the obstruction of large arteries to the legs. In treating PVD, he has studied both open surgical and endovascular techniques, including the use of various grafts, and stents. His work helped popularize the minimally invasive technique of subintimal angioplasty in the U.S.</p>

Elsevier Profile

EMR ID

4123

Biography

<p>Evan C. Lipsitz, MD, MBA, is Chief, Division of Vascular and Endovascular Surgery, Medical Director, Vascular Diagnostic Laboratory, and Professor, Cardiothoracic and Vascular Surgery at Montefiore Einstein. His clinical focus encompasses the full range of vascular treatments, including endovascular thoracic and abdominal aortic aneurysm repair, aortic dissection, carotid artery disease and stroke prevention, lower extremity peripheral arterial disease and limb salvage, endovascular and open treatments for aneurysms and peripheral arterial disease.</p><p>In 1990, Dr. Lipsitz received his Doctor of Medicine from Columbia University&rsquo;s College of Physicians and Surgeons. He pursued postdoctoral training at Presbyterian Hospital, Columbia-Presbyterian Medical Center, completing his internship and residency in general surgery as well as an ECMO clinical and research fellowship. He later came to Montefiore Einstein, completing his vascular surgery fellowship in 1999. In 2017, Dr. Lipsitz received his Master of Business Administration from The Heller School for Social Policy and Management, Brandeis University.</p><p>Dr. Lipsitz's research focus includes the utilization of endovascular graft technology for treating thoracic and abdominal aneurysms. He has been an investigator in clinical trials of numerous grafts and has evaluated the efficacy of wireless pressure sensors and endostaples as adjunctive therapies utilized with these grafts. Dr. Lipsitz has also focused research on limb salvage and the treatment of lower extremity peripheral vascular disease (PVD). In treating PVD, he has studied both open surgical and endovascular techniques, including the use of various grafts and stents. His work has helped popularize the minimally invasive technique of subintimal angioplasty technique in the United States. He is also interested in healthcare policy and development, particularly in the area of quality metrics. Dr. Lipsitz has published more than 110 papers in scientific journals and over 40 book chapters. He also is a reviewer for several journals and is active in healthcare policy and management.</p><p>Dr. Lipsitz is board certified by the National Board of Medical Examiners and is a member of several professional societies including the Society for Vascular Ultrasound, the Vascular and Endovascular Surgery Society and the International Society of Endovascular Specialists. He has been named in <em>New York Magazine&rsquo;s</em> &ldquo;Best Doctors in New York&rdquo; as well as Castle Connolly&rsquo;s &ldquo;Top Doctors: New York Metro Area&rdquo; for several years.</p>

Is Open Scheduling

Off

I. Martin Levy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/cb5531f0-d545-11eb-af57-a79c115e5bbd.jpg

First Name

I. Martin

Last Name

Levy

NPI

1164593554

Faculty ID

4025

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p><span>Dr. Levy graduated from SUNY Binghamton and earned his medical degree from New York Medical College. He was an assistant resident in General Surgery at Metropolitan Hospital Center, Chief Resident in Orthopaedic Surgery at Montefiore and Fellow in the Sports Medicine Service at the Hospital for Special Surgery. Dr. Levy is Attending Orthopaedic Surgeon at Montefiore. He was the Director of the Sports Medicine Service from 1983-1990 and chief of the service in 2001.</span></p>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>Sports medicine, ligament and cartilage injuries of the knee, throwing injuries and instability of the shoulder, arthroscopy </p>

Research Focus

<p>Meniscal biomechanics, ACL reconstruction, epidemiology of football injuries on artificial surfaces, measurement tools for graduate education, epidemiology of injuries of dogs participating in canine agility </p>

Elsevier Profile

EMR ID

3371

Biography

<p>Martin Levy, MD, is a board-certified, fellowship-trained orthopedic surgeon specializing in sports medicine and arthroscopy. He is also an expert in anterior cruciate ligament reconstruction and revision of failed ACL surgery. Dr. Levy is a Professor of Orthopedic Surgery at our Albert Einstein College of Medicine as well as the Orthopedic Surgery Residency Program Director. His experience is extensive, notably in arthroscopy and meniscus surgery, including meniscal repair, arthroscopic stabilization of shoulder instability, arthroscopic repair of SLAP injuries and other shoulder maladies in athletes, and arthroscopic and open solutions for patellar instability.</p><p>He earned his medical degree from New York Medical College. He was an assistant resident in general surgery at Metropolitan Hospital Center, Chief Resident in Orthopedic Surgery at Montefiore and fellow in the Sports Medicine Service at the Hospital for Special Surgery.</p><p>Dr. Levy&rsquo;s early research focused on soft tissue biomechanics and injury epidemiology. More recently, he has concentrated on optimizing the surgical skills of orthopedic surgery residents using operant learning methodologies. He has created a surgical skills program for teaching the behaviors needed to use orthopedic tools fluently.</p>

Visit Type ID

2494

Is Open Scheduling

On

Benjamin J. Levy

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/77319260-3b85-11ed-879a-0b46ee55c5ba.jpg

First Name

Benjamin

Last Name

Levy

NPI

1427465319

Faculty ID

17270

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Patellofemoral conditions, as well as the shoulder, elbow, and ankle. He has expertise in operative and nonoperative management of patellofemoral instability, ligamentous reconstruction of the knee, cartilage repair and restoration, meniscal pathology, shoulder instability, and rotator cuff pathology.

Research Focus

Dr. Levy has a passion for research and teaching and has authored numerous peer-reviewed articles and textbook chapters in the field of sports medicine, with publications in the American Journal of Sports Medicine, Arthroscopy, Journal of Shoulder and Elbow Surgery, and many others. He has a specific interest in patellofemoral research.

Elsevier Profile

EMR ID

171574

Biography

<p>Benjamin J. Levy, MD, is Assistant Director, Orthopaedic Research and Assistant Professor, Orthopedic Surgery and Sports Medicine at Montefiore Einstein. Dr. Levy specializes in orthopedic sports medicine, specifically arthroscopic surgery of the knee, with a particular interest in patellofemoral conditions, as well as the shoulder, elbow and ankle. He has expertise in operative and nonoperative management of patellofemoral instability, ligamentous reconstruction of the knee, cartilage repair and restoration, meniscal pathology, shoulder instability and rotator cuff pathology.</p><p>After obtaining his Bachelor of Science in neuroscience from the University of Michigan in 2010, Dr. Levy came to Montefiore Einstein, where he earned his Doctor of Medicine in 2014 and completed his residency in orthopedic surgery in 2019. Dr. Levy pursued an adult and pediatric sports medicine fellowship at the University of Connecticut, completing it in 2020. During that time, he served as the team physician fellow for the University of Connecticut and Quinnipiac University D-1 athletic programs.</p><p>Dr. Levy has a passion for research and teaching, and has authored numerous peer-reviewed articles and textbook chapters in the field of sports medicine, with publications in the <em>American Journal of Sports Medicine, Arthroscopy</em>, the <em>Journal of Shoulder and Elbow Surgery</em> and many others. He has a specific interest in patellofemoral research and serves as a reviewer for several top journals in the field. He has also given many national presentations.</p><p>Dr. Levy is board certified for the American Board of Orthopedic Surgery. He is a member of the American Academy of Orthopaedic Surgeons and a candidate member of the American Orthopaedic Society for Sports Medicine. Dr. Levy is a recipient of several academic awards for research, including the Arciero-Warner Research Award from the New England Shoulder and Elbow Society. He is an &ldquo;Emerging Leader&rdquo; in the American Orthopaedic Association.</p>

Is Open Scheduling

On

Zocdoc Link

Paul E. Levin

https://assets.montefioreeinstein.org/profiles/images/physphoto/Levin_Paul_MD_420x504.jpg

First Name

Paul

Last Name

Levin

NPI

1093890394

Faculty ID

10243

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

<p>General orthopedics, nonoperative management of musculoskeletal conditions, fracture surgery and complications of fractures</p>

Research Focus

<p>Patient/physician communication and patient autonomy</p>

Elsevier Profile

EMR ID

4653

Biography

<p>&nbsp;</p>Paul E. Levin, MD, joined Montefiore and our Albert Einstein College of Medicine in 2004 and is the Vice Chair of the Department of Orthopedics as well as the Director of the Department of Orthopedics, Moses Campus. At Einstein, he serves as Professor of Orthopedic Surgery. He is a board-certified orthopedic specialist with expertise in general orthopedics, the nonoperative management of musculoskeletal conditions, fracture surgery and complications of fractures.<br /><br />He received his medical degree from SUNY Downstate Medical Center in 1980 and completed his orthopedic residency at Montefiore in 1985. He subsequently completed a fellowship in orthopedic traumatology at the University of Texas and a second fellowship in fracture care at the Kantosspital in Basel, Switzerland.<br /><br />Dr. Levin teaches classes in bioethics and a course in Patients, Doctors and Communities, both of which focus on collaboration among patients and professionals regarding healthcare delivery. Known for exploring treatment options with his patients along with the desire to identify a strategy for successful care without surgical intervention, he has been called on to lecture on patient-clinician communication and surgical safety. Dr. Levin is a fellow of the American Academy of Orthopedic Surgeons (AAOS) and chairman of the organization's Committee on Ethics and Lectures.<p>&nbsp;</p>

Visit Type ID

2494

Is Open Scheduling

On